FIKCX vs. FBIOX
FIKCX (Fidelity Advisor Health Care Fund Class Z) and FBIOX (Fidelity Select Biotechnology Portfolio) are both Health & Biotech Equities funds from Fidelity. Over the past 5 years, FIKCX returned 0.50%/yr vs 6.76%/yr for FBIOX. Their correlation of 0.83 suggests significant overlap in exposure. FIKCX charges 0.59%/yr vs 0.69%/yr for FBIOX.
Performance
FIKCX vs. FBIOX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FIKCX achieves a 1.22% return, which is significantly lower than FBIOX's 11.03% return.
FIKCX
- 1D
- 1.14%
- 1M
- 4.48%
- YTD
- 1.22%
- 6M
- -0.13%
- 1Y
- 22.67%
- 3Y*
- 3.56%
- 5Y*
- 0.50%
- 10Y*
- —
FBIOX
- 1D
- 2.80%
- 1M
- 6.82%
- YTD
- 11.03%
- 6M
- 8.61%
- 1Y
- 58.91%
- 3Y*
- 20.04%
- 5Y*
- 6.76%
- 10Y*
- 11.69%
FIKCX vs. FBIOX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
FIKCX Fidelity Advisor Health Care Fund Class Z | 1.22% | 14.61% | -5.73% | 4.20% | -12.74% | 11.66% | 21.55% | 28.39% | -11.04% |
FBIOX Fidelity Select Biotechnology Portfolio | 11.03% | 36.38% | 7.26% | 10.09% | -15.87% | -12.26% | 38.62% | 36.12% | -16.77% |
Correlation
The correlation between FIKCX and FBIOX is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.80 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.81 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2018 | 0.83 |
The correlation between FIKCX and FBIOX has been stable across timeframes, ranging from 0.80 to 0.85 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FIKCX vs. FBIOX — Risk / Return Rank
FIKCX
FBIOX
FIKCX vs. FBIOX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Health Care Fund Class Z (FIKCX) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FIKCX | FBIOX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.34 | ||
| Sortino ratioReturn per unit of downside risk | -1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.44 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 1.72 | 7.66 | -5.94 |
| Martin ratioReturn relative to average drawdown | 4.55 | 23.32 | -18.78 |
Loading charts...
Drawdowns
FIKCX vs. FBIOX - Drawdown Comparison
The maximum FIKCX drawdown since its inception was -29.19%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for FIKCX and FBIOX.
Loading charts...
Drawdown Indicators
| FIKCX | FBIOX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -29.19% | -71.98% | +42.79% |
Max Drawdown (1Y)Largest decline over 1 year | -13.35% | -7.62% | -5.73% |
Max Drawdown (3Y)Largest decline over 3 years | -25.31% | -27.83% | +2.52% |
Max Drawdown (5Y)Largest decline over 5 years | -29.19% | -44.87% | +15.68% |
Max Drawdown (10Y)Largest decline over 10 years | — | -48.66% | — |
Current DrawdownCurrent decline from peak | -4.99% | 0.00% | -4.99% |
Average DrawdownAverage peak-to-trough decline | -9.26% | -23.60% | +14.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.05% | 2.50% | +2.55% |
Volatility
FIKCX vs. FBIOX - Volatility Comparison
The current volatility for Fidelity Advisor Health Care Fund Class Z (FIKCX) is 5.87%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 8.04%. This indicates that FIKCX experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FIKCX | FBIOX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.87% | 8.04% | -2.17% |
Volatility (6M)Calculated over the trailing 6-month period | 12.67% | 17.08% | -4.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.45% | 21.36% | -4.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.47% | 25.03% | -6.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.29% | 26.26% | -5.97% |
FIKCX vs. FBIOX - Expense Ratio Comparison
FIKCX has a 0.59% expense ratio, which is lower than FBIOX's 0.69% expense ratio.
Dividends
FIKCX vs. FBIOX - Dividend Comparison
FIKCX's dividend yield for the trailing twelve months is around 11.34%, more than FBIOX's 6.06% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 6.06% | 2.47% | 1.21% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% |
FIKCX Fidelity Advisor Health Care Fund Class Z | 11.34% | 11.48% | 0.00% | 0.00% | 0.00% | 5.71% | 5.86% | 0.61% | 4.65% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
FIKCX and FBIOX have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FBIOX has higher volatility (8.04%) compared to FIKCX (5.87%). In terms of maximum drawdown, FIKCX dropped -29.19% vs FBIOX's -71.98%.
FBIOX currently has the higher Sharpe Ratio (2.74 vs 1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FIKCX and FBIOX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer